Zepbound, el nuevo medicamento aprobado por la FDA para perder pesonews2023-11-13T10:01:53+00:00November 13th, 2023|The New York Times|
Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Showsnews2023-11-12T05:20:43+00:00November 12th, 2023|The New York Times|
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovynews2023-11-09T01:02:09+00:00November 9th, 2023|The New York Times|
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.news2023-11-08T18:34:20+00:00November 8th, 2023|The New York Times|
Los medicamentos cotra la obesidad tienen sobreprecio, pero esto puede cambiarnews2023-10-26T09:02:55+00:00October 26th, 2023|The New York Times|
How Much Do Ozempic and Wegovy Cost? Not What You Think.news2023-10-22T07:00:20+00:00October 22nd, 2023|The New York Times|
The Wegovy Shortage Drags On, Leaving Patients in Limbonews2023-10-05T09:00:15+00:00October 5th, 2023|The New York Times|
Does Ozempic Stop Working Over Time? Why Weight Loss Can Plateaunews2023-09-19T08:29:26+00:00September 19th, 2023|The New York Times|
The Disruptive Power of Weight Loss Drugs Is Being Felt Beyond Pharmanews2023-09-02T20:23:31+00:00September 2nd, 2023|The New York Times|
Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s Economynews2023-08-28T22:32:35+00:00August 28th, 2023|The New York Times|
